Health Information
Return to Infectious Diseases Overview
More on Infectious Diseases
- Adenovirus Infections
- AIDS / HIV
- Chickenpox
- Fevers
- Haemophilus Influenzae Infections
- Hand-Foot-Mouth Disease
- Hepatitis
- Herpes Simplex Virus / Cold Sores
- HIV Home Care
- Human Immunodeficiency Virus (HIV)
- Human Parainfluenza Viruses (HPIVs)
- Impetigo
- Infectious Diseases
- Meningitis
- Meningococcal Infections
- Mumps
- Scarlet Fever
- Varicella
For Patients, Families & Visitors
Return to Infectious Diseases Overview
More on Infectious Diseases
Infectious Diseases
Anne E. Gershon, MD
Director, Division of Infectious DiseasesThe outstanding infectious diseases programs at NewYork-Presbyterian Morgan Stanley Children's Hospital specialize in the management of infants, children and adolescents with acute or chronic bacterial, viral or fungal infections. Our dedicated physicians provide diagnostic and treatment consultation to clinical services throughout the hospitals and community, including neonatology, oncology, transplantation, medicine and pulmonology. In addition, the infectious diseases specialists are involved in numerous clinical research projects that include the development of new antimicrobial therapies and vaccines for children.
The Division of Infectious Diseases combines clinical care with research, public health and epidemiology. It is comprised of seven physicians with expertise in a wide spectrum of infectious diseases in children.
The Division's infectious diseases specialists diagnose and treat viral, bacterial, fungal, and parasitic pathogens. This remarkable team is internationally renowned as leaders in the use of antiviral therapy and the management of varicella-zoster virus, herpes simplex, and respiratory syncytial virus infections. The physicians bring a depth of experience to treating HIV/AIDS; infections in immunocomprised children, with cancer and organ transplants; those with endocarditis; tuberculosis; osteomyelitis; pneumonia; and congenital or neonatal viral infections. In addition, they are skilled in treating patients with multi-drug resistant organisms.
Our infectious diseases specialists serve as consultants for the Centers for Disease Control and Prevention, the Food and Drugs Administration, and the National Institutes of Health. National organizations such as the National Association of Children's Hospitals and Related Institutions (NACHRI) and the Cystic Fibrosis Foundation, as well as pharmaceutical and biotechnology companies, also seek their expertise.
The Division has established a Clinical Research Program to support the startup and execution of Clinical Research. A dedicated program manager, experienced investigators, and research coordinators are available to provide infrastructure clinical expertise and administrative coordination for all Clinical Research performed within the division and with investigators from other specialties participating in collaborative research. This program supports industry, government, foundation, and investigator initiated research in antimicrobial agents, vaccines, epidemiology, and ID-related technology.
The team also participates in the Clinical Immunization Safety Assessment (CISA) Network, which is a collaborative effort between the Centers for Disease Control & Prevention (CDC) and seven clinical centers including Columbia University. The primary goals of the network are to improve the scientific understanding of vaccine safety issues through research and to serve as a source of clinical expertise in evaluation of adverse events following immunization.
Contact
- Pediatric Infectious Diseases
-
Directions
(212) 305-9445
